
NASDAQHealthcareBiotechnology
أحدث البيانات المتاحة
72.67 US$
−0.03 US$ · -0.04%
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota.
الإغلاق السابق
72.67 US$
−0.03 US$ · -0.04%
تستخدم الأوقات اليومية المنطقة الزمنية ET. قد تتأخر بيانات السوق.
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota.
نطاق اليوم
السعر الحالي 72.67 US$
نطاق 52 أسبوعًا
السعر الحالي 72.67 US$
تستخدم الأوقات اليومية المنطقة الزمنية ET. قد تتأخر بيانات السوق.
نقاط GoAI
احتفاظ
تقييم
48
قيمة عادلة
المشاعر
58
مختلط
المخاطر
41
مخاطر أعلى من المعتاد
الزخم
62
زخم متزايد
بحث كامل عن GoAI
تابع للاطلاع على أدلة ومحفزات ومخاطر أعمق.
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota.
نطاق اليوم
السعر الحالي 72.67 US$
نطاق 52 أسبوعًا
السعر الحالي 72.67 US$
الربحية كنسبة مئوية من الإيرادات المعلنة.
الإيرادات
الدخل التشغيلي
صافي الدخل
| البند (USD) | السنة المالية 2026 | السنة المالية 2025 | السنة المالية 2024 | السنة المالية 2023 | السنة المالية 2022 |
|---|---|---|---|---|---|
| الإيرادات | 1.22 مليار USD | 1.22 مليار USD | 1.16 مليار USD | 1.14 مليار USD | 1.11 مليار USD |
| تكلفة البضاعة المباعة | 415.97 مليون USD | 429.36 مليون USD | 389.34 مليون USD | 366.89 مليون USD | 349.1 مليون USD |
| الربح الإجمالي | 799.07 مليون USD | 790.27 مليون USD | 769.73 مليون USD | 769.82 مليون USD | 756.5 مليون USD |
| البحث والتطوير | 94.77 مليون USD | 99.5 مليون USD | 96.66 مليون USD | 92.49 مليون USD | 87.14 مليون USD |
| مصاريف البيع والمصاريف العمومية والإدارية | 452.42 مليون USD | 415.1 مليون USD | 393.32 مليون USD | 352.44 مليون USD | 339 مليون USD |
| نفقات التشغيل | 547.18 مليون USD | 688.02 مليون USD | 563.04 مليون USD | 470.87 مليون USD | 459.91 مليون USD |
| دخل الفوائد | — | 3.89 مليون USD | 3.32 مليون USD | 3.41 مليون USD | 794 ألف USD |
| مصاريف الفوائد | 5.41 مليون USD | 8.51 مليون USD | 15.74 مليون USD | 11.22 مليون USD | 11.31 مليون USD |
| الاستهلاك والإطفاء | 97.36 مليون USD | 109.9 مليون USD | 111.71 مليون USD | 107.24 مليون USD | 101.07 مليون USD |
| الدخل التشغيلي | 251.89 مليون USD | 102.26 مليون USD | 206.69 مليون USD | 298.94 مليون USD | 296.59 مليون USD |
| صافي الدخل | 181.86 مليون USD | 73.4 مليون USD | 168.11 مليون USD | 285.26 مليون USD | 272.05 مليون USD |
تم تحديث حقائق الشركة 22 نوفمبر 2026.
النتائج المعلنة مع توقعات الإجماع المتاحة.
النتائج المعلنة مع توقعات الإجماع المتاحة.
قد تتغير تقديرات المحللين الخارجيين، وهي ليست توصيات من GoAI.
متوسط الهدف
71.67 US$
انخفاض محتمل بنسبة 1.38%صناديق متداولة تفصح عن تعرضها لهذا السهم.
State Street SPDR S&P 500 ETF1557.T22.09 مليار0.02%119.93 ترليون JPY0.09%113,700 JP¥-3.19%
Vanguard S&P 500 ETFVOO302.46 مليون0.02%1 ترليون USD0.03%635.54 US$-3.41%
Vanguard Morningstar Total Stock Market ETFVTI285.65 مليون0.02%689.3 مليار USD0.03%340.02 US$-3.52%
Vanguard Morningstar Small-Cap ETFVB255.45 مليون0.14%78.7 مليار USD0.03%270.68 US$-2.56%
Invesco S&P 500 Equal Weight ETFRSP205.78 مليون0.20%98.53 مليار USD0.20%207.44 US$-1.98%
Sequoia ETFSEQ164.32 مليون2.57%6.41 مليار USD0.99%50.39 US$-1.71%
iShares Core S&P 500 ETFIVV153.11 مليون0.02%803.41 مليار USD0.03%693.71 US$-3.52%
Vanguard Morningstar Small-Cap Growth ETFVBK142.87 مليون0.33%22.5 مليار USD0.05%298.35 US$-3.85%
State Street SPDR S&P 500 ETF1557.T
Vanguard S&P 500 ETFVOO
Vanguard Morningstar Total Stock Market ETFVTI
Vanguard Morningstar Small-Cap ETFVB
Invesco S&P 500 Equal Weight ETFRSP
Sequoia ETFSEQ
iShares Core S&P 500 ETFIVV
Vanguard Morningstar Small-Cap Growth ETFVBKالمحتوى المُنشأ بالذكاء الاصطناعي وبيانات السوق المتأخرة لأغراض معلوماتية وتعليمية فقط، ولا تُعد نصيحة استثمارية.